Exelixis, Inc.Profile
|
|
Share Price & Volume
| Previous Close | $41.28 | |
| Open | -1.79% | $40.54 |
| Day Low | -2.52% | $40.24 |
| Day High | +0.82% | $41.62 |
| 52-Week Low | -21.56% | $32.38 |
| 52-Week High | +20.20% | $49.62 |
| Day Volume | 2,325,317 | |
| Average Volume | 2,785,563 | |
| EPS (TTM) | $2.78 | |
| P/E (TTM) | 14.94x | |
| FWD P/E (NTM) | 13.53x | |
| Next Earnings Date | May 12, 2026 |
| Market Cap | 11,138,719,189 | |
| Shares Outstanding (Millions) | 268,112,148 | |
| Dividend | - | |
| Beta | 0.41 | |
| ROE | 0.36% | |
| ROA | 0.19% |
Analyst Ratings and Price Targets
Current:
$41.55
Average:
$47.18
(+13.57%)
Low:
$35.00
(-15.75%)
High:
$54.00
(+29.98%)
| RBC Capital | Maintains | Sector Perform | $43.00 | +3.50% | Mar 1, 2026 |
| HC Wainwright & Co. | Maintains | Buy | $54.00 | +29.98% | Feb 12, 2026 |
| RBC Capital | Maintains | Sector Perform | $46.00 | +10.72% | Feb 11, 2026 |
| Stifel | Maintains | Hold | $44.00 | +5.91% | Feb 11, 2026 |
| Wells Fargo | Maintains | Equal-Weight | $35.00 | -15.75% | Feb 11, 2026 |
| Barclays | Maintains | Equal-Weight | $44.00 | +5.91% | Feb 4, 2026 |
| HC Wainwright & Co. | Reiterates | Buy | $52.00 | +25.17% | Feb 3, 2026 |
| Morgan Stanley | Maintains | Equal-Weight | $49.00 | +17.94% | Feb 2, 2026 |
| HC Wainwright & Co. | Maintains | Buy | $52.00 | +25.17% | Jan 27, 2026 |
| HC Wainwright & Co. | Maintains | Buy | $52.00 | +25.17% | Jan 8, 2026 |
| Morgan Stanley | Downgrades | Equal-Weight | $48.00 | +15.54% | Jan 8, 2026 |
Headquarters
Alameda, CA, USA
Sector
Industry
# of Employees
1,147